REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
04/06/2026
Back to search
Official data from USPTO
PULMOBIOTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
04/07/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
08/11/2020
Registration date
04/06/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/06/2021
Last transaction
04/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
3
Owner type
12
Owner location
Barcelona, ES
Examiner
GUROK, GALINA
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the word "PULMOBIOTICS" in blue, stylized letters with a droplet design over the first letter "I" the word. The white seen merely represents background and is not a part of the mark.
Holders and representatives
Holders
Fundació Centre de Regulació Genòmica
Representatives
JUSTIN R. YOUNG DINEFF TRADEMARK LAW LIMITED
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for treating respiratory diseases and cancer; cultures of microorganisms for medical use; mediumsmedia for bacteriological culture; bacterial preparations for medical and veterinary use; vaccines; vaccine adjuvants; drug delivery agents in the form of bacteria that facilitate the delivery of pharmaceutical preparations; antigensvaccines; pharmaceutical agents affecting metabolism; therapeutic preparations of bacterial origintherapeutic pharmaceutical for the treatment of respiratory diseases; live biotherapeutic preparationscultures of microorganisms for medical or veterinary use; recombinant live biotherapeutic preparationscultures of microorganisms for medical or veterinary use; biological preparations for medical purposes for the treatment of respiratory diseases and cancer; probiotic bacterial preparations for medical use; living cells for medical use
Class 42
Science and technology servicespharmaceutical products development; scientific research services; biomedical research services; medical and pharmacological research services; research and development services in the field of bacteriology; research and development services in the field of vaccines; development of pharmaceutical preparations and medicines; product development of therapeutic molecules; informationadvice and consultancy relating to the aforesaid services
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/06/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/19/2021
PUBO
PUBLISHED FOR OPPOSITION
01/19/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/30/2020
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
12/16/2020
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
12/11/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/10/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
12/10/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/10/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
12/10/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/10/2020
DOCK
ASSIGNED TO EXAMINER
12/04/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/15/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/13/2020
NWAP
NEW APPLICATION ENTERED
08/14/2020
Continuous trademark protection
Get notified about every new filing that threatens PULMOBIOTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.